AnalystsInsight

John Freeman (Raymond James): Analyst Track Record and Price‑Target Accuracy

How often John Freeman’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,014 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • John Freeman ranks #84 of 1,000 analysts in Exent’s scoring (5.0★).
  • 32.9% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 225 days; 73.5% of calls were up 12 months later.
  • Most‑covered stocks: CRGY, FANG, OXY, APA.

John Freeman’s track record at a glance

John Freeman of Raymond James ranks #84 of the 1,000 analysts Exent scores, with a 5.0★ rating and a focus on energy. Over a 7‑year lookback, 32.9% of John’s price targets were reached, 19.5 points below the 52.4% average across all analysts.

MetricJohn FreemanAll analysts
Price‑target hit rate32.9%52.4%
Median days to hit target225 days91 days
Calls up after 12 months73.5%64.0%
Median 12‑month return of calls+30.7%+13.4%
Hit rate, last 2 years26.9%—
Average worst drop after a call−17.8%—
Ratings in the sample1,014—
Stocks covered28—

How fast price targets were reached

Time to reach the targetJohn Freeman
Under 30 days6.4%
30–90 days12.1%
90–180 days17.9%
Over 180 days63.6%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks John Freeman covers most

StockRatings in the sample
CRGY32
FANG29
OXY28
APA23
VNOM23
TXO23
MTDR22
DVN21

In the past year John’s ratings were 96% Buy, 4% Hold and 0% Sell.

Recent ratings (shown with a 30-day delay)

DateStockActionRatingPrice target
Sep 17, 2026EOGReiterated: BuyBuy$186.00
Sep 17, 2026FANGReiterated: BuyBuy$255.00
Sep 14, 2026DVNReiterated: BuyBuy$67.00
Sep 10, 2026NOGReiterated: BuyBuy$31.00
Sep 10, 2026CRGYReiterated: BuyBuy$20.00
Sep 9, 2026EXEReiterated: BuyBuy$147.00
Sep 2, 2026APAReiterated: BuyBuy$54.00
Sep 2, 2026WHKReiterated: BuyBuy$37.00
Sep 1, 2026ARReiterated: BuyBuy$55.00
Aug 27, 2026PRReiterated: BuyBuy$29.00
Aug 24, 2026COPReiterated: BuyBuy$0.00
Jul 31, 2026VNOMReiterated: BuyBuy$57.00
  • Sep 17, 2026
    Stock
    EOG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $186.00
  • Sep 17, 2026
    Stock
    FANG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $255.00
  • Sep 14, 2026
    Stock
    DVN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $67.00
  • Sep 10, 2026
    Stock
    NOG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $31.00
  • Sep 10, 2026
    Stock
    CRGY
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $20.00
  • Sep 9, 2026
    Stock
    EXE
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $147.00
  • Sep 2, 2026
    Stock
    APA
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $54.00
  • Sep 2, 2026
    Stock
    WHK
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $37.00
  • Sep 1, 2026
    Stock
    AR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $55.00
  • Aug 27, 2026
    Stock
    PR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $29.00
  • Aug 24, 2026
    Stock
    COP
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.00
  • Jul 31, 2026
    Stock
    VNOM
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $57.00

Live ratings from John Freeman and the other top‑ranked analysts, and the stocks where they agree, are in Exent Stocks Radar.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 17, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Stocks Radar shows John Freeman’s live ratings and those of the other top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring John Freeman ranks #84 of 1,000 with a 5.0★ rating. 32.9% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 73.5% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

John Freeman’s success rate is 66.0% by the ranking source and 32.9% by Exent’s price-target hit-rate backtest, with a median of 225 days to reach a target.

John Freeman (Raymond James) covers 28 stocks, mostly in energy. The most frequently rated are CRGY, FANG, OXY, APA, VNOM.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.